BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

IVAX Diagnostics, Inc. Announces Initial Closing of Investment and Prepares for Expansion and Acquisitions


7/6/2011 10:42:35 AM

MIAMI--(BUSINESS WIRE)--IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, announced today that it has consummated the initial transactions contemplated by its previously announced stock purchase agreement with ERBA Diagnostics Mannheim GmbH. At the initial closing of the investment, IVAX Diagnostics received an aggregate purchase price of $5,000,000 in cash, or $0.75 per share, and issued to ERBA Diagnostics Mannheim 6,666,667 shares of IVAX Diagnostics’ common stock and warrants to purchase an additional 20,000,000 shares of IVAX Diagnostics’ common stock. The warrants have an exercise price per share equal to $0.75 and have a five-year term. The purchase price of $0.75 per share and the warrant exercise price of $0.75 per share constitute a premium of 14% above the average closing price of a share of IVAX Diagnostics’ common stock on the NYSE Amex during the five trading days immediately prior to April 8, 2011, the date on which the stock purchase agreement was originally publicly announced.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->